AtriCure (ATRC) Interest & Investment Income (2010 - 2026)
AtriCure (ATRC) posted quarterly Interest & Investment Income of $1.2 million for Q2 2026, up 25.29% year-over-year from $941000.0 in Q2 2025, and down 5.3% quarter-over-quarter from $1.2 million in Q1 2026.
AtriCure (ATRC) Interest & Investment Income (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has reported Interest & Investment Income for 17 consecutive years, with $1.2 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Interest & Investment Income rose 25.29% year-over-year to $1.2 million; the TTM figure through Jun 2026 stood at $4.9 million (up 10.12% YoY), while the FY2025 annual figure was $4.5 million, up 1.01% from the prior year.
- Interest & Investment Income slipped to $1.2 million in Q2 2026 per ATRC's latest filing, from $1.2 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.3 million in Q4 2025 and bottomed at -$2.3 million in Q1 2022.
- Historically, Interest & Investment Income has averaged $693555.6 across 5 years, with a median of $1.0 million in 2023.
- Annual changes were most pronounced in 2022 — Interest & Investment Income plunged 1845.52% — and 2023, when it soared 314.03%.
- AtriCure's Interest & Investment Income stood at $668000.0 in 2022, then soared by 55.84% to $1.0 million in 2023, then grew by 15.66% to $1.2 million in 2024, then rose by 10.55% to $1.3 million in 2025, then slipped by 11.42% to $1.2 million in 2026.
- Business Quant data shows ATRC's Interest & Investment Income at $1.2 million in Q2 2026, $1.2 million in Q1 2026, and $1.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 4.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 20.89 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -119.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 3.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -64.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -64.00 Mn |
| 10 | AtriCure | 2.39 Bn | 2.22 Bn | 118.63 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Mn |
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 941,000.00 |
| Mar 31, 2025 | 1.04 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 997,000.00 |
| Mar 31, 2024 | 952,000.00 |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | 915,000.00 |
| Jun 30, 2023 | 961,000.00 |
| Mar 31, 2023 | 1.04 Mn |
| Dec 31, 2022 | 668,000.00 |
| Sep 30, 2022 | -691,000.00 |
| Jun 30, 2022 | -449,000.00 |
| Mar 31, 2022 | -2.34 Mn |
| Dec 31, 2021 | -1.30 Mn |
| Sep 30, 2021 | 117,000.00 |